This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aldieri, E. Articles by Bosia, A. Search for Related Content PubMed PubMed Citation Articles by Aldieri, E. Articles by Bosia, A.

Simian Virus 40 Infection Down-Regulates the Expression of Nitric Oxide Synthase in Human Mesothelial Cells

¹ Department of Genetics, Biology and Biochemistry, University of Torino and Research Center on Experimental Medicine, Torino, Italy; ² Department of Oncology, Azienda Sanitaria Ospedaliera Santi Antonio e Biagio, Alessandria, Italy; ³ Department of Chemistry IFM, University of Torino, Torino, Italy; and ⁴ Interdepartmental Center "G. Scansetti" for Studies on Asbestos and other Toxic Particulates, University of Torino, Italy

The cytotoxic effects of asbestos are partly mediated by the production of free radicals, including nitric oxide (NO). SV40 has been suggested to synergize with asbestos in the pathogenesis of malignant mesothelioma. Crocidolite asbestos fibers induced in human mesothelial and malignant mesothelioma cells a significant increase of NO synthase activity and expression, which was absent in SV40-infected cells. Furthermore, SV40 infection prevented the NFB activation elicited by crocidolite in both mesothelial and mesothelioma cells. These data suggest that SV40, by inhibiting the synthesis of NO, could favor the survival of transformed, potentially neoplastic cells.

This article has been cited by other articles:

				S. Doublier, C. Riganti, C. Voena, C. Costamagna, E. Aldieri, G. Pescarmona, D. Ghigo, and A. Bosia RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells Mol. Cancer Res., October 1, 2008; 6(10): 1607 - 1620. [Abstract] [Full Text] [PDF]

				C. Riganti, S. Doublier, C. Costamagna, E. Aldieri, G. Pescarmona, D. Ghigo, and A. Bosia Activation of Nuclear Factor-{kappa}B Pathway by Simvastatin and RhoA Silencing Increases Doxorubicin Cytotoxicity in Human Colon Cancer HT29 Cells Mol. Pharmacol., August 1, 2008; 74(2): 476 - 484. [Abstract] [Full Text] [PDF]

				A. Sartore-Bianchi, F. Gasparri, A. Galvani, L. Nici, J. W. Darnowski, D. Barbone, D. A. Fennell, G. Gaudino, C. Porta, and L. Mutti Bortezomib Inhibits Nuclear Factor-{kappa}B Dependent Survival and Has Potent In vivo Activity in Mesothelioma Clin. Cancer Res., October 1, 2007; 13(19): 5942 - 5951. [Abstract] [Full Text] [PDF]

				C. Riganti, S. Orecchia, F. Silvagno, G. Pescarmona, P. G. Betta, E. Gazzano, E. Aldieri, D. Ghigo, and A. Bosia Asbestos Induces Nitric Oxide Synthesis in Mesothelioma Cells via Rho Signaling Inhibition Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 746 - 756. [Abstract] [Full Text] [PDF]

				R. Cutrone, J. Lednicky, G. Dunn, P. Rizzo, M. Bocchetta, K. Chumakov, P. Minor, and M. Carbone Some Oral Poliovirus Vaccines Were Contaminated with Infectious SV40 after 1961 Cancer Res., November 15, 2005; 65(22): 10273 - 10279. [Abstract] [Full Text] [PDF]

				M. E. Ramos-Nino, G. Vianale, T. Sabo-Attwood, L. Mutti, C. Porta, N. Heintz, and B. T. Mossman Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase Mol. Cancer Ther., May 1, 2005; 4(5): 835 - 842. [Abstract] [Full Text] [PDF]